🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Experimental Treatment Acquiring Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Followers are encouraged to message these accounts directly for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Separately, a robust market exists on messaging services, where groups with numerous of members share “before and after” images, injection guides and assertions of next-day British shipping. Sellers market the substance there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the successor to Ozempic.

Healthcare Experts Voice Concerns

However, physicians and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could result in individuals administering products of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the rising price of licensed weight loss products such as Mounjaro.

Legal Status and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the UK, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.

Several influencers try to circumvent the rules by calling to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Material Removal

According to TikTok, the service has removed problematic content and banned related hashtags and search suggestions. The company stated it was committed to maintaining the service safe and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Investigations also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, filled with images of weight loss, positive testimonials and detailed instructions for mixing or injecting at residence.

Within minutes of entering one community, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor sent an instruction manual and promised delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about body mass, medical conditions or past usage.

Product Information and Costs

Within these groups, messages display black plastic parcels with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with sterile water, or pre-filled pens typically priced at £160 for 20 milligrams. When questioned how long a pen should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for Telegram stated it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting substances they can’t verify. Although the research behind this drug is valid, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was sterile,” she said.

Her team has already seen patients harmed by personal administration from unverified sources. “We understand the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they said, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to possibly serious medical dangers”.